BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29510220)

  • 1. Modulation of key lipid raft constituents in primary rat hepatocytes by fumonisin B
    Burger HM; Abel S; Gelderblom WCA
    Food Chem Toxicol; 2018 May; 115():34-41. PubMed ID: 29510220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation of the lipid metabolism as a model for cellular resistance to fumonisin B1-induced cytotoxic effects in vitro.
    Riedel S; Abel S; Burger HM; van der Westhuizen L; Swanevelder S; Gelderblom WC
    Prostaglandins Leukot Essent Fatty Acids; 2016 Jun; 109():39-51. PubMed ID: 27269712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fumonisin B
    Riedel S; Abel S; Burger HM; Swanevelder S; Gelderblom WCA
    Biochim Biophys Acta Biomembr; 2024 Jun; 1866(5):184310. PubMed ID: 38479610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered lipid parameters in hepatic subcellular membrane fractions induced by fumonisin B1.
    Burger HM; Abel S; Snijman PW; Swanevelder S; Gelderblom WC
    Lipids; 2007 Apr; 42(3):249-61. PubMed ID: 17393230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fumonisin B1 on the levels and fatty acid composition of selected lipids in rat liver in vivo.
    Gelderblom WC; Smuts CM; Abel S; Snyman SD; Van der Westhuizen L; Huber WW; Swanevelder S
    Food Chem Toxicol; 1997 Jul; 35(7):647-56. PubMed ID: 9301647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of an altered lipid phenotype by two cancer promoting treatments in rat liver.
    Riedel S; Abel S; Swanevelder S; Gelderblom WC
    Food Chem Toxicol; 2015 Apr; 78():96-104. PubMed ID: 25656646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fumonisin B1 on protein and lipid synthesis in primary rat hepatocytes.
    Gelderblom WC; Smuts CM; Abel S; Snyman SD; Cawood ME; van der Westhuizen L; Swanevelder S
    Food Chem Toxicol; 1996 Apr; 34(4):361-9. PubMed ID: 8641662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in essential fatty acid patterns associated with normal liver regeneration and the progression of hepatocyte nodules in rat hepatocarcinogenesis.
    Abel S; Smuts CM; de Villiers C; Gelderblom WC
    Carcinogenesis; 2001 May; 22(5):795-804. PubMed ID: 11323400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipids and delta6-desaturase activity alterations in rat liver microsomal membranes induced by fumonisin B1.
    Gelderblom WC; Moritz W; Swanevelder S; Smuts CM; Abel S
    Lipids; 2002 Sep; 37(9):869-77. PubMed ID: 12458622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered lipid profile, oxidative status and hepatitis B virus interactions in human hepatocellular carcinoma.
    Abel S; De Kock M; van Schalkwyk DJ; Swanevelder S; Kew MC; Gelderblom WC
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):391-9. PubMed ID: 19782547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipidomic analysis of human primary hepatocytes following LXR activation with GW3965 identifies AGXT2L1 as a main target associated to changes in phosphatidylethanolamine.
    Santinha D; Klopot A; Marques I; Ellis E; Jorns C; Johansson H; Melo T; Antonson P; Jakobsson T; Félix V; Gustafsson JÅ; Domingues MR; Mode A; Helguero LA
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105558. PubMed ID: 31783151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of casein and soy-protein on alpha-linolenic acid metabolism in rats.
    Noguchi A; Takita T; Suzuki K; Nakamura K; Innami S
    J Nutr Sci Vitaminol (Tokyo); 1992 Dec; 38(6):579-91. PubMed ID: 1363922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol alters the lipid composition, metabolism and peroxide level in senescent rat hepatocytes.
    Momchilova A; Petkova D; Staneva G; Markovska T; Pankov R; Skrobanska R; Nikolova-Karakashian M; Koumanov K
    Chem Biol Interact; 2014 Jan; 207():74-80. PubMed ID: 24183824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aflatoxin B
    Mary VS; Arias SL; Otaiza SN; Velez PA; Rubinstein HR; Theumer MG
    Environ Toxicol; 2017 Jun; 32(6):1711-1724. PubMed ID: 28181396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of fumonisin B
    Szabó A; Szabó-Fodor J; Fébel H; Mézes M; Bajzik G; Kovács M
    Physiol Int; 2016 Sep; 103(3):321-333. PubMed ID: 28229635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of fatty acid biosynthesis as a possible mechanism for the mitoinhibitory effect of fumonisin B1 in primary rat hepatocytes.
    Gelderblom WC; Abel S; Smuts CM; Swanevelder S; Snyman SD
    Prostaglandins Leukot Essent Fatty Acids; 1999 Oct; 61(4):225-34. PubMed ID: 10574646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fumonisin B
    Szabó A; Fébel H; Ali O; Kovács M
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2019 Nov; 36(11):1722-1739. PubMed ID: 31437116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long chain fatty acids on lipid and glucose metabolism in monolayer cultures of bovine hepatocytes.
    Mashek DG; Grummer RR
    J Dairy Sci; 2003 Jul; 86(7):2390-6. PubMed ID: 12906057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative damage and fumonisin B1-induced toxicity in primary rat hepatocytes and rat liver in vivo.
    Abel S; Gelderblom WC
    Toxicology; 1998 Nov; 131(2-3):121-31. PubMed ID: 9928627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCP-2/SCP-x gene ablation alters lipid raft domains in primary cultured mouse hepatocytes.
    Atshaves BP; McIntosh AL; Payne HR; Gallegos AM; Landrock K; Maeda N; Kier AB; Schroeder F
    J Lipid Res; 2007 Oct; 48(10):2193-211. PubMed ID: 17609524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.